Key result
A national survey of 9,553 patients found that anti-coagulant thromboprophylaxis was prescribed to 88% when indicated, while 13% of hospital-associated VTE episodes were potentially preventable.
Why the study?
Following introduction of England's national VTE Prevention Programme in 2010, little data existed regarding VTE prevention practice or non-fatal hospital-associated VTE.
What is the current practice of VTE prevention and the rate of hospital-associated VTE in England following the introduction of a national programme?
Cross-Sectional (n=9,553)
Yes
What is the current practice of VTE prevention and the rate of hospital-associated VTE in England following the introduction of a national programme?
The national VTE prevention programme in England has achieved high prescription rates (88%), though areas for improvement remain in missed doses and patient information provision.
Answers are grounded in this paper and cite their sources.
Supports sustained national VTE prevention programmes; leaves open targeted improvements to reduce preventable events.
A national Venous Thromboembolism (VTE) Prevention Programme was introduced in England in 2010, with limited subsequent study of its impact. Whilst the National Outcomes Framework reports VTE deaths related to hospitalisation annually, there are little data regarding VTE prevention practice or non-fatal VTE associated with hospitalisation. We report the first national thrombosis survey undertaken in collaboration with Getting It Right First Time. 98 Trusts (103 sites, 67% of 144 invited) participated in at least one survey, contributing data regarding VTE prevention in 9553 patients. Anti-coagulant thromboprophylaxis was prescribed to 88% (when indicated), with 8.1% of patients missing doses. Written patient information was provided to 31%. Of 4595 episodes of hospital-associated VTE, 13% were considered potentially preventable. The survey highlights the success of the national programme and areas for improvement in delivery of thromboprophylaxis and patient information.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (2022) conducted a cross-sectional in Hospital-associated venous thromboembolism (n=9,553). Venous Thromboembolism (VTE) Prevention Programme was evaluated on Anti-coagulant thromboprophylaxis prescription when indicated. A national survey of 9,553 patients found that anti-coagulant thromboprophylaxis was prescribed to 88% when indicated, while 13% of hospital-associated VTE episodes were potentially preventable.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: